Videos

Anna Cabeca, DO, FACOG, discusses dehydroepiandrosterone and associated misunderstandings.

Explore the research on oxytocin's role beyond labor and bonding as Anna Cabeca, DO, FACOG, triple board certified ob-gyn, sheds light on its impact on longevity, sexual health, and overall well-being at the A4M conference in Las Vegas.

The panel discusses the importance of discussing the immunizations with patients now, as well as the value of them in future seasons.

JoAnn Vensko Pinkerton, MD, discusses how fezolinetant provides relief for postmenopausal women experiencing hot flashes and night sweats.

In the third installment of RSV Roundtable, our panel discusses the impact nirsevimab has had this RSV season.

Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, outlines treatment options for uterine fibroids in patients with different needs.

Toby Maurer, MD, professor at University of California, San Francisco, discusses dermatologic conditions commonly seen in pediatric patients.

Toby Maurer, MD, professor at University of California, San Francisco, discusses the clinical pearls of inflammatory vulvovaginal conditions and treatment.

Toby Maurer, MD, professor at University of California, San Francisco, discusses common skin conditions seen in female patients, along with the best methods of treating these conditions.

Last year’s historic RSV season left many wondering if this was going to become a recurring trend. Physicians weigh in on what they are seeing at their institutions in terms of infection rates.

Kirstin E. Leitner, MD, assistant professor of clinical obstetrics and gynecology at Penn Medicine, discusses how the artificial intelligence program "Penny" can be used to improve care in obstetrics and gynecology.

Elizabeth Cherot, MD, FACOG, chief executive officer of March of Dimes, discusses the 2023 March of Dimes report card, as well as the implications the findings have on maternal health.

Robert H. Hopkins, Jr, MD, discusses the importance of pregnant women receiving vaccines against respiratory diseases to protect themselves and their infants.

Experts close their panel on OAB by identifying treatment pathways for patients who have an unsatisfactory response to third-line therapy.

James A. Simon, MD, discusses how clinicians can help menopausal women manage sexual dysfunction.

James A Simon, MD, discusses the link between hot flashes and poor sleep quality, and how clinicians can help their patients manage sleep disorders.

An overview of patient monitoring strategies experts use to establish individualized followup with patients receiving therapy for OAB in the third-line setting.

Focused discussion on effectively communicating expectations for third-line therapies with patients being treated for OAB.

Steven R. Goldstein, MD, discusses holes in clinicians' understanding of the endometrium, and how these knowledge gaps can be remedied.

Michael E. Lewiecki, MD, discusses risk factors of osteoporosis in midlife women, and how clinicians can measure and manage bone health.

Mary Jane Minkin, MD, FACOG, MSCP, discusses key takeaways from The Menopause Society 2023 Annual Meeting, held in Philadelphia, Pennsylvania from September 27-30.

Peter Minneci, MD, MHSc, discusses a study evaluating a new algorithm capable of accurately identifying benign lesions in female patients.

Barbara A. Dehn, NP, Vice President of Women’s Health at Peppy Health, discusses topics presented at The Menopause Society which will help her in her practice.

Nanette F. Santoro, MD, chair of OBGYN at the University of Colorado School of Medicine, discusses new research on fezolinetant as a nonhormone method for managing hot flashes at the 2023 Menopause Society Annual Meeting.

Experts provide their perspective on the advent of third-line therapy in OAB and discuss details in the clinical process of transitioning patients out of the second-line setting.

Panelists identify key goals of therapy when treating OAB and identify resources that may aid in patient education.

Shared insight on strategies used to converse with and educate patients on pharmacologic treatment options for OAB, including the potential for adverse events tied to therapy.

Genevieve Neal-Perry, MD, discusses how fezolinetant is effective for treating vasomotor symptoms.